Skip to content

Innovation1 Biotech Inc.

company.status.inactive

CIK 1629205fmd_0QH030SJ5R3GG6P6XR490RAZDEManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Sep 01, 2014 to Feb 29, 2024, 38 periods

Latest annual · FY2023

Millions
Total revenues
0
Gross profit
0
Operating income
(1)
Net income
(6)
Free cash flow
(1)

Latest quarter · Q1 FY2024

Millions
Total revenues
0
Gross profit
0
Operating income
0
Net income
(0)
Free cash flow
0
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
n/m
Revenue, 5 yearsFY2018 to FY2023
n/m
Net income, 5 yearsFY2018 to FY2023
n/m

Innovation1 Biotech Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$0$010-K 2024-01-17 · proof
Gross profit$0$010-K 2024-01-17 · proof
Operating income-$1.4 million-$5.2 million10-K 2024-01-17 · proof
Net income-$6 million-$40.9 million10-K 2024-01-17 · proof
Cash from operating activities-$620,195-$3.1 million10-K 2024-01-17 · proof
Free cash flow-$620,195-$3.1 million10-K 2024-01-17 · proof
Total assets$75,993$44 million-99.8%10-K 2024-01-17 · proof
Total liabilities$3.5 million$41.1 million-91.5%10-K 2024-01-17 · proof
Cash and cash equivalents$49,849$156,486-68.1%10-K 2024-01-17 · proof
What was Innovation1 Biotech Inc.'s revenue in fiscal 2023?
Innovation1 Biotech Inc. reported revenue of $0 for fiscal 2023 (the year ended Aug 31, 2023), against $0 the year before. Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What was Innovation1 Biotech Inc.'s gross profit in fiscal 2023?
Innovation1 Biotech Inc. reported gross profit of $0 for fiscal 2023 (the year ended Aug 31, 2023), against $0 the year before. Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What was Innovation1 Biotech Inc.'s operating income in fiscal 2023?
Innovation1 Biotech Inc. reported operating income of -$1.4 million for fiscal 2023 (the year ended Aug 31, 2023), against -$5.2 million the year before. Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What was Innovation1 Biotech Inc.'s net income in fiscal 2023?
Innovation1 Biotech Inc. reported net income of -$6 million for fiscal 2023 (the year ended Aug 31, 2023), against -$40.9 million the year before. Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What was Innovation1 Biotech Inc.'s cash from operating activities in fiscal 2023?
Innovation1 Biotech Inc. reported cash from operating activities of -$620,195 for fiscal 2023 (the year ended Aug 31, 2023), against -$3.1 million the year before. Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What was Innovation1 Biotech Inc.'s free cash flow in fiscal 2023?
Innovation1 Biotech Inc. reported free cash flow of -$620,195 for fiscal 2023 (the year ended Aug 31, 2023), against -$3.1 million the year before. Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What are Innovation1 Biotech Inc.'s total assets?
As of Aug 31, 2023, Innovation1 Biotech Inc. reported total assets of $75,993, against $44 million a year earlier (-99.8%). Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What are Innovation1 Biotech Inc.'s total liabilities?
As of Aug 31, 2023, Innovation1 Biotech Inc. reported total liabilities of $3.5 million, against $41.1 million a year earlier (-91.5%). Source: the 10-K filed with the SEC on Jan 17, 2024. SEC
What are Innovation1 Biotech Inc.'s cash and cash equivalents?
As of Aug 31, 2023, Innovation1 Biotech Inc. reported cash and cash equivalents of $49,849, against $156,486 a year earlier (-68.1%). Source: the 10-K filed with the SEC on Jan 17, 2024. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1629205&period_type=annual&limit=5"

Information only, not investment advice.